Tumor Embolization Using a Small-Bore Guide via the Distal Radial Artery Approach: Report of Five Consecutive Cases.

Journal of neuroendovascular therapy Pub Date : 2025-01-01 Epub Date: 2025-05-15 DOI:10.5797/jnet.cr.2025-0008
Satoshi Horiguchi, Yoshinori Maki, Takeshi Satow, Yuto Mitsuno, Kota Nakajima
{"title":"Tumor Embolization Using a Small-Bore Guide via the Distal Radial Artery Approach: Report of Five Consecutive Cases.","authors":"Satoshi Horiguchi, Yoshinori Maki, Takeshi Satow, Yuto Mitsuno, Kota Nakajima","doi":"10.5797/jnet.cr.2025-0008","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Cardiologists use the distal radial artery (dRA) approach in daily clinical practice. This method is gradually being applied in neuroendovascular treatment. However, limited studies have been reported concerning tumor embolization using small-bore guidance via dRA.</p><p><strong>Case presentation: </strong>Five consecutive tumoral cases underwent endovascular embolization via the dRA approach. The right dRA was punctured, with manual confirmation of pulsation or under the guidance of ultrasonography, using a 22-G plastic cannulation needle. After the insertion of a 0.021-inch guidewire, a dilator of a 4-Fr sheath enlarged the puncture site. The 22-G plastic cannulation needle was replaced with an 18-G cannulation needle, and a 0.035 guidewire was inserted to introduce a small-bore guide. A TEMPO4 (Cordis, Miami Lakes, FL, USA; outer diameter: 1.35 mm) or a 3.6-Fr JB2 (Gadelius Medical, Tokyo, Japan; outer diameter: 1.2 mm) was used in 4 cases to convey embolization materials, whereas a 4-Fr, 16-cm sheath (Terumo, Tokyo, Japan; outer diameter: 2 mm) combined with a 4-Fr SY3 (Gadelius Medical; outer diameter: 1.4 mm) was used in 1 case. Trisacryl gelatin microspheres or <i>n</i>-butyl-2-cyanoacrylate were used as embolization materials. Hemostasis was achieved with PreludeSYNC DISTAL (Merit Medical, South Jordan, UT, USA), and the median time ± standard deviation of hemostasis was 2.00 ± 0.77 h. No complications occurred after embolization.</p><p><strong>Conclusion: </strong>Tumor embolization using small-bore guide via the dRA approach was completed without any complications.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086020/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroendovascular therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5797/jnet.cr.2025-0008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Cardiologists use the distal radial artery (dRA) approach in daily clinical practice. This method is gradually being applied in neuroendovascular treatment. However, limited studies have been reported concerning tumor embolization using small-bore guidance via dRA.

Case presentation: Five consecutive tumoral cases underwent endovascular embolization via the dRA approach. The right dRA was punctured, with manual confirmation of pulsation or under the guidance of ultrasonography, using a 22-G plastic cannulation needle. After the insertion of a 0.021-inch guidewire, a dilator of a 4-Fr sheath enlarged the puncture site. The 22-G plastic cannulation needle was replaced with an 18-G cannulation needle, and a 0.035 guidewire was inserted to introduce a small-bore guide. A TEMPO4 (Cordis, Miami Lakes, FL, USA; outer diameter: 1.35 mm) or a 3.6-Fr JB2 (Gadelius Medical, Tokyo, Japan; outer diameter: 1.2 mm) was used in 4 cases to convey embolization materials, whereas a 4-Fr, 16-cm sheath (Terumo, Tokyo, Japan; outer diameter: 2 mm) combined with a 4-Fr SY3 (Gadelius Medical; outer diameter: 1.4 mm) was used in 1 case. Trisacryl gelatin microspheres or n-butyl-2-cyanoacrylate were used as embolization materials. Hemostasis was achieved with PreludeSYNC DISTAL (Merit Medical, South Jordan, UT, USA), and the median time ± standard deviation of hemostasis was 2.00 ± 0.77 h. No complications occurred after embolization.

Conclusion: Tumor embolization using small-bore guide via the dRA approach was completed without any complications.

经桡动脉远端入路应用小口径导管栓塞肿瘤:连续5例报告。
目的:心脏病专家在日常临床实践中使用桡动脉远端入路。该方法正逐步应用于神经血管内治疗。然而,关于使用经dRA的小口径导引进行肿瘤栓塞的研究报道有限。病例介绍:连续5例肿瘤经dRA入路行血管内栓塞术。采用22g塑料置管针穿刺右侧dRA,人工确认搏动或超声引导下穿刺。在插入0.021英寸的导丝后,用4-Fr鞘扩张器扩大穿刺部位。将22g塑料穿刺针更换为18g穿刺针,插入0.035导丝,引入小口径导针。A TEMPO4 (Cordis, Miami Lakes, FL, USA;外径:1.35 mm)或3.6 fr JB2(日本东京Gadelius Medical;4例使用外径:1.2 mm)输送栓塞材料,而4- fr, 16cm鞘(Terumo, Tokyo, Japan;外径:2mm)与4-Fr SY3 (Gadelius Medical;外径:1.4 mm) 1例。用三丙烯酸明胶微球或2-氰基丙烯酸正丁酯作为栓塞材料。采用PreludeSYNC远端(Merit Medical, South Jordan, UT, USA)止血,止血中位时间±标准差为2.00±0.77 h,栓塞后无并发症发生。结论:小口径导管经dRA入路栓塞肿瘤成功,无并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信